07 Jan 2001

AscoTop® 2,5 (AscoTop® 2,5 mg Filmtabletten) - Deutschland

Updated: 07 Jan 2001

AscoTop® 2,5 mg; -Schmelztabletten

Akutbehandl. von Migränekopfschmerzen mit od. ohne Aura.

AscoTop® 2,5 Description, Presentation and Dosage

AscoTop® 2,5 Description

AscoTop® 2,5 Drug Class Description

Einzelstoffe

AscoTop® 2,5 Drug Description

1 Filmtbl. enth.: Zolmitriptan 2,5 mg.

AscoTop® 2,5 Generic Name

AscoTop® 2,5 mg Filmtabletten

AscoTop® 2,5 Presentation

AscoTop® 2,5 Presentation

AscoTop® 2,5 mg; -Schmelztabletten

AscoTop® 2,5 Manufacturer

AstraZeneca/Promed

Related Learning Zones

COPD Knowledge Centre

COPD Knowledge Centre

The COPD Knowledge Centre has been designed to provide healthcare professionals with free access to educational materials and disease awareness information. This includes information on the epidemiology, pathophysiology and symptoms of COPD and the latest guidelines for the diagnosis, treatment and management of the disease.

COPD-specific resources such as videosguidelinesinfographics, materials for your patients, upcoming events, useful websites and symposium videos and materials from ATS 2015 are available free of charge.

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

AscoTop® 2,5 Dosage

AscoTop® 2,5 Adult Dosage

Lactose, mikrokristalline Cellulose, Natriumcarboxymethylstärke (Typ A), Magnesiumstearat, Hypromellose, Macrogol 400, Macrogol 8000, Eisenoxidhydrat gelb (E 172), Titandioxid (E 171). Natriumhydrogencarbonat.

AscoTop® 2,5 Child Dosage


AscoTop® 2,5 mg Schmelz- tabletten
Zus.: 1 Schmelztbl. enth.: Zolmitriptan 2,5 mg.
Weit. Bestandteile: Aspartam, Citronensäure, hochdisperses Siliciumdioxid, Crospovidon, Magnesiumstearat, D-Mannitol, Mikrokristalline Cellulose, Orangenaroma SN027512,

AscoTop® 2,5 Precautions, Reactions and Contraindications

AscoTop® 2,5 Special Precautions

AscoTop® 2,5 Special Precautions

Mittelschwere, schwere od. unzureichend eingest. leichte Hypertonie. Myokardinfarkt, koronare Herzkrankheit, Koronarspasmen (Prinzmetal-Angina), arterielle Verschlußkrankheit, Schlaganfall od. transistorische ischämische Attacken in der Anamnese. Symptome einer koronaren Herzkrankheit. Gleichz. Verabreichung von Ergotamin, Ergotaminderivaten (einschl. Methysergid), Sumatriptan, Naratriptan u. and. 5HT1B/1D-Agonisten, Kreatinin-Clearance

Related Drugs - Neurological Disorders

Back to top